GlassScriptPhysician profile
David Garcia
NPI 1265417893
$3,453.17
in general payments reported to CMS, 2019-2025
21 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $2,081 · 2021: $320 · 2022: $138 · 2023: $156 · 2024: $99.96 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $1,933.47 | 2019-2021 | |
| Abbvie INC. | $351.42 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $176.81 | 2019-2023 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2025 | Camzyos |
| Takeda Pharmaceuticals U.S.A., INC. | $122.01 | 2019-2021 | |
| Abiomed | $99.96 | 2024 | Impella |
| Boston Scientific Corporation | $94.57 | 2019 | |
| Merck Sharp & Dohme LLC | $86.52 | 2023 | Dificid |
| Braintree Laboratories, INC. | $79.69 | 2022 | |
| Shire North American Group INC | $75.71 | 2019 | |
| Ferring Pharmaceuticals INC. | $64.79 | 2019-2021 | |
| Janssen Biotech, INC. | $62.04 | 2019-2021 | |
| Qol Medical, LLC | $40.33 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $35.43 | 2020-2021 | |
| Pfizer INC. | $29.81 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15.84 | 2020 | |
| Romark Laboratories, Lc | $13.92 | 2019 | |
| Redhill Biopharma INC. | $13.74 | 2021 | |
| Evoke Pharma, INC. | $11.31 | 2021 | |
| Allergan, INC. | $11.28 | 2019 | |
| Vivus LLC | $9.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.